APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Discovery Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Drug Discovery Software Market Analysis and Forecast 2026-2032

30 January 2026196 pages

Choose your research edition.

Industry ResearchAI Drug Discovery Software Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Discovery Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Discovery Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Discovery Software Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global AI Drug Discovery Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Drug Discovery Software include Merck KGaA, Atomwise Inc, BenevolentAI, BullFrog AI, Genesis Therapeutics, Pharma.AI, Recursion Pharmaceuticals, Verge Genomics and Schrödinger, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Drug Discovery Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Drug Discovery Software, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Drug Discovery Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Drug Discovery Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Drug Discovery Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Drug Discovery Software revenue, projected growth trends, production technology, application and end-user industry.

AI Drug Discovery Software Segment by Company

Merck KGaA

Atomwise Inc

BenevolentAI

BullFrog AI

Genesis Therapeutics

Pharma.AI

Recursion Pharmaceuticals

Verge Genomics

Schrödinger, Inc.

XtalPi

Iktos

AI Drug Discovery Software Segment by Type

Cloud Based

On Premise

AI Drug Discovery Software Segment by Application

CRO and Universities

Pharmaceutical Company

Test Lab

AI Drug Discovery Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Drug Discovery Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Drug Discovery Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Discovery Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Discovery Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud Based Major Player Table 3. On Premise Major Player Table 4. Global AI Drug Discovery Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. CRO and Universities Major Player Table 6. Pharmaceutical Company Major Player Table 7. Test Lab Major Player Table 8. AI Drug Discovery Software Industry Trends Table 9. AI Drug Discovery Software Industry Drivers Table 10. AI Drug Discovery Software Industry Opportunities and Challenges Table 11. AI Drug Discovery Software Industry Restraints Table 12. Global AI Drug Discovery Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global AI Drug Discovery Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global AI Drug Discovery Software Market Share by Region (2021-2026) Table 15. Global AI Drug Discovery Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global AI Drug Discovery Software Market Share by Region (2027-2032) Table 17. Global AI Drug Discovery Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global AI Drug Discovery Software Revenue Market Share by Players (2021-2026) Table 19. Global AI Drug Discovery Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global AI Drug Discovery Software Key Players Headquarters & Area Served Table 21. Global AI Drug Discovery Software Players, Product Type & Application Table 22. Global AI Drug Discovery Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global AI Drug Discovery Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global AI Drug Discovery Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global AI Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global AI Drug Discovery Software Revenue Market Share by Type (2021-2026) Table 29. Global AI Drug Discovery Software Revenue Market Share by Type (2027-2032) Table 30. Global AI Drug Discovery Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global AI Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global AI Drug Discovery Software Revenue Market Share by Application (2021-2026) Table 34. Global AI Drug Discovery Software Revenue Market Share by Application (2027-2032) Table 35. Merck KGaA Company Information Table 36. Merck KGaA Business Overview Table 37. Merck KGaA AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Merck KGaA AI Drug Discovery Software Product Portfolio Table 39. Merck KGaA Recent Development Table 40. Atomwise Inc Company Information Table 41. Atomwise Inc Business Overview Table 42. Atomwise Inc AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Atomwise Inc AI Drug Discovery Software Product Portfolio Table 44. Atomwise Inc Recent Development Table 45. BenevolentAI Company Information Table 46. BenevolentAI Business Overview Table 47. BenevolentAI AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BenevolentAI AI Drug Discovery Software Product Portfolio Table 49. BenevolentAI Recent Development Table 50. BullFrog AI Company Information Table 51. BullFrog AI Business Overview Table 52. BullFrog AI AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. BullFrog AI AI Drug Discovery Software Product Portfolio Table 54. BullFrog AI Recent Development Table 55. Genesis Therapeutics Company Information Table 56. Genesis Therapeutics Business Overview Table 57. Genesis Therapeutics AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genesis Therapeutics AI Drug Discovery Software Product Portfolio Table 59. Genesis Therapeutics Recent Development Table 60. Pharma.AI Company Information Table 61. Pharma.AI Business Overview Table 62. Pharma.AI AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pharma.AI AI Drug Discovery Software Product Portfolio Table 64. Pharma.AI Recent Development Table 65. Recursion Pharmaceuticals Company Information Table 66. Recursion Pharmaceuticals Business Overview Table 67. Recursion Pharmaceuticals AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Recursion Pharmaceuticals AI Drug Discovery Software Product Portfolio Table 69. Recursion Pharmaceuticals Recent Development Table 70. Verge Genomics Company Information Table 71. Verge Genomics Business Overview Table 72. Verge Genomics AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Verge Genomics AI Drug Discovery Software Product Portfolio Table 74. Verge Genomics Recent Development Table 75. Schrödinger, Inc. Company Information Table 76. Schrödinger, Inc. Business Overview Table 77. Schrödinger, Inc. AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Schrödinger, Inc. AI Drug Discovery Software Product Portfolio Table 79. Schrödinger, Inc. Recent Development Table 80. XtalPi Company Information Table 81. XtalPi Business Overview Table 82. XtalPi AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. XtalPi AI Drug Discovery Software Product Portfolio Table 84. XtalPi Recent Development Table 85. Iktos Company Information Table 86. Iktos Business Overview Table 87. Iktos AI Drug Discovery Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Iktos AI Drug Discovery Software Product Portfolio Table 89. Iktos Recent Development Table 90. North America AI Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 91. North America AI Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 92. North America AI Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 93. North America AI Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 94. North America AI Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America AI Drug Discovery Software Revenue by Country (2021-2026) & (US$ Million) Table 96. North America AI Drug Discovery Software Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe AI Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe AI Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe AI Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe AI Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe AI Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe AI Drug Discovery Software Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe AI Drug Discovery Software Revenue by Country (US$ Million) & (2027-2032) Table 104. China AI Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 105. China AI Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 106. China AI Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 107. China AI Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia AI Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia AI Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia AI Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia AI Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia AI Drug Discovery Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia AI Drug Discovery Software Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia AI Drug Discovery Software Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA AI Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA AI Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA AI Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA AI Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA AI Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA AI Drug Discovery Software Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA AI Drug Discovery Software Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. AI Drug Discovery Software Image Figure 2. Global AI Drug Discovery Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Discovery Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud Based Image Figure 5. On Premise Image Figure 6. Global AI Drug Discovery Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI Drug Discovery Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. CRO and Universities Image Figure 9. Pharmaceutical Company Image Figure 10. Test Lab Image Figure 11. Global AI Drug Discovery Software Market Size (US$ Million) & (2021-2032) Figure 12. Global AI Drug Discovery Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global AI Drug Discovery Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global AI Drug Discovery Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global AI Drug Discovery Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Drug Discovery Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global AI Drug Discovery Software Revenue Market Share by Type (2021-2032) Figure 19. Global AI Drug Discovery Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Drug Discovery Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global AI Drug Discovery Software Revenue Market Share by Application (2021-2032) Figure 22. North America AI Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America AI Drug Discovery Software Revenue Share by Type (2021-2032) Figure 24. North America AI Drug Discovery Software Revenue Share by Application (2021-2032) Figure 25. North America AI Drug Discovery Software Revenue Share by Country (2021-2032) Figure 26. United States AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe AI Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe AI Drug Discovery Software Revenue Share by Type (2021-2032) Figure 31. Europe AI Drug Discovery Software Revenue Share by Application (2021-2032) Figure 32. Europe AI Drug Discovery Software Revenue Share by Country (2021-2032) Figure 33. Germany AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China AI Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China AI Drug Discovery Software Revenue Share by Type (2021-2032) Figure 43. China AI Drug Discovery Software Revenue Share by Application (2021-2032) Figure 44. Asia AI Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia AI Drug Discovery Software Revenue Share by Type (2021-2032) Figure 46. Asia AI Drug Discovery Software Revenue Share by Application (2021-2032) Figure 47. Asia AI Drug Discovery Software Revenue Share by Region (2021-2032) Figure 48. Japan AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA AI Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA AI Drug Discovery Software Revenue Share by Type (2021-2032) Figure 56. SAMEA AI Drug Discovery Software Revenue Share by Application (2021-2032) Figure 57. SAMEA AI Drug Discovery Software Revenue Share by Country (2021-2032) Figure 58. Brazil AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt AI Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • On Premise
Applications
  • CRO and Universities
  • Pharmaceutical Company
  • Test Lab
Companies covered
  • Merck KGaA
  • Atomwise Inc
  • BenevolentAI
  • BullFrog AI
  • Genesis Therapeutics
  • Pharma.AI
  • Recursion Pharmaceuticals
  • Verge Genomics
  • Schrödinger, Inc.
  • XtalPi
  • Iktos

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Drug Discovery Software Market by Type
  3. 1.2.1 Global AI Drug Discovery Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud Based
  5. 1.2.3 On Premise
  6. 1.3 AI Drug Discovery Software Market by Application
  7. 1.3.1 Global AI Drug Discovery Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 CRO and Universities
  9. 1.3.3 Pharmaceutical Company
  10. 1.3.4 Test Lab
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 AI Drug Discovery Software Market Dynamics
  1. 2.1 AI Drug Discovery Software Industry Trends
  2. 2.2 AI Drug Discovery Software Industry Drivers
  3. 2.3 AI Drug Discovery Software Industry Opportunities and Challenges
  4. 2.4 AI Drug Discovery Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Drug Discovery Software Market Perspective (2021-2032)
  2. 3.2 Global AI Drug Discovery Software Growth Trends by Region
  3. 3.2.1 Global AI Drug Discovery Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Drug Discovery Software Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Drug Discovery Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Drug Discovery Software Revenue by Players
  2. 4.1.1 Global AI Drug Discovery Software Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Drug Discovery Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Drug Discovery Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Drug Discovery Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Drug Discovery Software Key Players Headquarters & Area Served
  7. 4.4 Global AI Drug Discovery Software Players, Product Type & Application
  8. 4.5 Global AI Drug Discovery Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Drug Discovery Software Market CR5 and HHI
  11. 4.6.3 2025 AI Drug Discovery Software Tier 1, Tier 2, and Tier 3
5 AI Drug Discovery Software Market Size by Type
  1. 5.1 Global AI Drug Discovery Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Discovery Software Revenue by Type (2021-2032)
  3. 5.3 Global AI Drug Discovery Software Revenue Market Share by Type (2021-2032)
6 AI Drug Discovery Software Market Size by Application
  1. 6.1 Global AI Drug Discovery Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Drug Discovery Software Revenue by Application (2021-2032)
  3. 6.3 Global AI Drug Discovery Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck KGaA
  2. 7.1.1 Merck KGaA Company Information
  3. 7.1.2 Merck KGaA Business Overview
  4. 7.1.3 Merck KGaA AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck KGaA AI Drug Discovery Software Product Portfolio
  6. 7.1.5 Merck KGaA Recent Developments
  7. 7.2 Atomwise Inc
  8. 7.2.1 Atomwise Inc Company Information
  9. 7.2.2 Atomwise Inc Business Overview
  10. 7.2.3 Atomwise Inc AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Atomwise Inc AI Drug Discovery Software Product Portfolio
  12. 7.2.5 Atomwise Inc Recent Developments
  13. 7.3 BenevolentAI
  14. 7.3.1 BenevolentAI Company Information
  15. 7.3.2 BenevolentAI Business Overview
  16. 7.3.3 BenevolentAI AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BenevolentAI AI Drug Discovery Software Product Portfolio
  18. 7.3.5 BenevolentAI Recent Developments
  19. 7.4 BullFrog AI
  20. 7.4.1 BullFrog AI Company Information
  21. 7.4.2 BullFrog AI Business Overview
  22. 7.4.3 BullFrog AI AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BullFrog AI AI Drug Discovery Software Product Portfolio
  24. 7.4.5 BullFrog AI Recent Developments
  25. 7.5 Genesis Therapeutics
  26. 7.5.1 Genesis Therapeutics Company Information
  27. 7.5.2 Genesis Therapeutics Business Overview
  28. 7.5.3 Genesis Therapeutics AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Genesis Therapeutics AI Drug Discovery Software Product Portfolio
  30. 7.5.5 Genesis Therapeutics Recent Developments
  31. 7.6 Pharma.AI
  32. 7.6.1 Pharma.AI Company Information
  33. 7.6.2 Pharma.AI Business Overview
  34. 7.6.3 Pharma.AI AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pharma.AI AI Drug Discovery Software Product Portfolio
  36. 7.6.5 Pharma.AI Recent Developments
  37. 7.7 Recursion Pharmaceuticals
  38. 7.7.1 Recursion Pharmaceuticals Company Information
  39. 7.7.2 Recursion Pharmaceuticals Business Overview
  40. 7.7.3 Recursion Pharmaceuticals AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Recursion Pharmaceuticals AI Drug Discovery Software Product Portfolio
  42. 7.7.5 Recursion Pharmaceuticals Recent Developments
  43. 7.8 Verge Genomics
  44. 7.8.1 Verge Genomics Company Information
  45. 7.8.2 Verge Genomics Business Overview
  46. 7.8.3 Verge Genomics AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Verge Genomics AI Drug Discovery Software Product Portfolio
  48. 7.8.5 Verge Genomics Recent Developments
  49. 7.9 Schrödinger, Inc.
  50. 7.9.1 Schrödinger, Inc. Company Information
  51. 7.9.2 Schrödinger, Inc. Business Overview
  52. 7.9.3 Schrödinger, Inc. AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Schrödinger, Inc. AI Drug Discovery Software Product Portfolio
  54. 7.9.5 Schrödinger, Inc. Recent Developments
  55. 7.10 XtalPi
  56. 7.10.1 XtalPi Company Information
  57. 7.10.2 XtalPi Business Overview
  58. 7.10.3 XtalPi AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 XtalPi AI Drug Discovery Software Product Portfolio
  60. 7.10.5 XtalPi Recent Developments
  61. 7.11 Iktos
  62. 7.11.1 Iktos Company Information
  63. 7.11.2 Iktos Business Overview
  64. 7.11.3 Iktos AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Iktos AI Drug Discovery Software Product Portfolio
  66. 7.11.5 Iktos Recent Developments
8 North America
  1. 8.1 North America AI Drug Discovery Software Revenue (2021-2032)
  2. 8.2 North America AI Drug Discovery Software Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Drug Discovery Software Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Drug Discovery Software Revenue by Type (2027-2032)
  5. 8.3 North America AI Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Drug Discovery Software Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Drug Discovery Software Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Drug Discovery Software Revenue by Application (2027-2032)
  9. 8.5 North America AI Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Drug Discovery Software Revenue by Country
  11. 8.6.1 North America AI Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Drug Discovery Software Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Drug Discovery Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Drug Discovery Software Revenue (2021-2032)
  2. 9.2 Europe AI Drug Discovery Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Drug Discovery Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Drug Discovery Software Revenue by Type (2027-2032)
  5. 9.3 Europe AI Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Drug Discovery Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Drug Discovery Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Drug Discovery Software Revenue by Application (2027-2032)
  9. 9.5 Europe AI Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Drug Discovery Software Revenue by Country
  11. 9.6.1 Europe AI Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Drug Discovery Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Drug Discovery Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Drug Discovery Software Revenue (2021-2032)
  2. 10.2 China AI Drug Discovery Software Revenue by Type (2021-2032)
  3. 10.2.1 China AI Drug Discovery Software Revenue by Type (2021-2026)
  4. 10.2.2 China AI Drug Discovery Software Revenue by Type (2027-2032)
  5. 10.3 China AI Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 10.4 China AI Drug Discovery Software Revenue by Application (2021-2032)
  7. 10.4.1 China AI Drug Discovery Software Revenue by Application (2021-2026)
  8. 10.4.2 China AI Drug Discovery Software Revenue by Application (2027-2032)
  9. 10.5 China AI Drug Discovery Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Drug Discovery Software Revenue (2021-2032)
  2. 11.2 Asia AI Drug Discovery Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Drug Discovery Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Drug Discovery Software Revenue by Type (2027-2032)
  5. 11.3 Asia AI Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Drug Discovery Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Drug Discovery Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Drug Discovery Software Revenue by Application (2027-2032)
  9. 11.5 Asia AI Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Drug Discovery Software Revenue by Country
  11. 11.6.1 Asia AI Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Drug Discovery Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Drug Discovery Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Drug Discovery Software Revenue (2021-2032)
  2. 12.2 SAMEA AI Drug Discovery Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Drug Discovery Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Drug Discovery Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Drug Discovery Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Drug Discovery Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Drug Discovery Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Drug Discovery Software Revenue by Country
  11. 12.6.1 SAMEA AI Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Drug Discovery Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Drug Discovery Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst